Compugen Ltd (NAS:CGEN)
$ 1.84 -0.06 (-3.16%) Market Cap: 170.50 Mil Enterprise Value: 73.00 Mil PE Ratio: 0 PB Ratio: 2.83 GF Score: 53/100

Compugen Ltd at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 09, 2021 / 03:00PM GMT
Release Date Price: $6.84 (+1.03%)
Albert Hwang

Hi, everybody. Welcome to the first day of the Morgan Stanley Global Healthcare Conference. I'd like to thank everyone for joining the Compugen fireside chat. My name is Albert Hwang. I'm Managing Director and Co-Head of the Healthcare Group in the Investment Banking division.

With me, I will let Anat introduce the management team, but love to get started as soon as I read the disclaimer here. So for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

So maybe with that, we only have 30 minutes. So love to get started here. Anat, if you could please kick off and introduce who you have with you and maybe give a 5-minute introduction to Compugen for those of the audience here that's new to the story. I think that will be a good way to kick off.

Anat Cohen;Dayag
Compugen Ltd. - CEO, President & Director

Sure. Thank you, Albert, and thanks, Morgan Stanley, for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot